- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Snapshot for GeoVax Labs Inc (GOVX)
| Open: | 0.4307 | Day's Range: | 0.4307 - 0.5000 | Volume: | 28,818 |
|---|---|---|---|---|---|
| Previous Close: | 0.4800 | 52wk Range: | 0.4307 - 0.9600 | 1-Yr Rtn: | -45.65% |
Key Statistics for GOVX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.1100 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 10.22 |
| Shares Outstanding (M) | 20.45 |
| 30 Day Average Volume | 29,879 |
| Price/Book (mrq) | 6.9834 |
| Price/Sale (ttm) | 3.6677 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/12/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GOVX
Company Profile & Key Executives for GOVX
GeoVax Labs Inc. is a biomedical company. The Company develops, manufactures, tests, conducts human trials, licenses, and commercializes human vaccines for diseases caused by HIV-1 (human immunodeficiency virus) [AIDS] and other infectious agents.
| Robert T McNally "Bob"President/CEO | Mark W ReynoldsCFO/Secretary |
| Harriet L RobinsonChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GOVX News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page